chr6-46161709-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001290072.2(ENPP5):āc.1051A>Gā(p.Ile351Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000992 in 1,613,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001290072.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENPP5 | NM_001290072.2 | c.1051A>G | p.Ile351Val | missense_variant | 5/5 | ENST00000371383.7 | NP_001277001.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENPP5 | ENST00000371383.7 | c.1051A>G | p.Ile351Val | missense_variant | 5/5 | 1 | NM_001290072.2 | ENSP00000360436.1 | ||
ENPP5 | ENST00000230565.3 | c.1051A>G | p.Ile351Val | missense_variant | 4/4 | 1 | ENSP00000230565.3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250344Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135366
GnomAD4 exome AF: 0.000105 AC: 154AN: 1460900Hom.: 0 Cov.: 33 AF XY: 0.0000936 AC XY: 68AN XY: 726746
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74394
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.1051A>G (p.I351V) alteration is located in exon 4 (coding exon 3) of the ENPP5 gene. This alteration results from a A to G substitution at nucleotide position 1051, causing the isoleucine (I) at amino acid position 351 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at